GO
Loading...

Vertex Pharmaceuticals Inc

More

  • Another Biotech CEO Bites The Dust Tuesday, 5 Jan 2010 | 3:18 PM ET
    James C. Mullen

    Talk about a blow to the ego. The shares may have since succumbed to the downdraft in the overall stock market, but when trading opened this morning Biogen Idec shot up around two percent. Investors were reacting to the news that the company's longtime CEO, Jim Mullen, is calling it quits.

  • Dow Gains 0.8% as Financials Rebound Monday, 2 Nov 2009 | 5:49 PM ET
    Winterizing Your Portfolio - A CNBC Special Report

    A late rally helped propel the Dow to a positive finish Monday as financial stocks rebounded.

  • Stocks Erase Gains as Financials Slide Monday, 2 Nov 2009 | 1:01 PM ET
    Winterizing Your Portfolio - A CNBC Special Report

    Stocks erased all of their gains Monday after an early surge due to a better-than-expected manufacturing report. Financials led the decline.

  • Biopharma's Bustin' Out All Over Monday, 2 Nov 2009 | 12:32 PM ET

    Over the past few days there's been a remarkable confluence of newsflow, most of it positive, out of biopharma. First the bad news.

  • Dow Jumps Over 100 After ISM Beat Monday, 2 Nov 2009 | 10:30 AM ET
    Winterizing Your Portfolio - A CNBC Special Report

    The Dow shot up more than 100 points Monday after a report showed manufacturing expanded more than expected last month.

  • Futures Regain Ground; Ford, Pharma Higher Monday, 2 Nov 2009 | 7:22 AM ET

    Stock futures pointed to a modest rebound ahead of the open Monday after the Dow and the S&P 500 experienced their biggest one-day percentage drops Friday since July 2.

  • Longest Monthly Streak for the Nasdaq in 14 Years? Thursday, 22 Oct 2009 | 7:26 AM ET

    There’s still a week-and-a-half left in the month, but the markets are currently maintaining yet another month of gains.

  • Your First Move For Thursday October 1st Wednesday, 30 Sep 2009 | 6:35 PM ET

    Here's our Fast Money Final Trade. Our gang gives you tomorrow's best trades, right now!

  • Four Hot Biotech Stocks to Buy: Analyst Thursday, 11 Jun 2009 | 10:41 AM ET

    Dr. Mark Monane, senior biotech analyst at Needham & Co., named some biotech stocks that look attractive.

  • Stocks Go Negative In Last Hour Tuesday, 28 Apr 2009 | 6:01 PM ET

    Stocks surrendered earlier gains and fell modestly on Tuesday largely due to fresh worries that major banks may need to raise more money.

  • Halftime Report: Stress Tests, Who's Making The Grade? Tuesday, 28 Apr 2009 | 1:11 PM ET

    Stocks traded only modestly lower Tuesday, despite concerns that if major banks need to raise more money a financial hurricane may be brewing.

  • Lightning Round: Cisco, US Steel and More Monday, 6 Apr 2009 | 8:26 PM ET

    Cramer makes the call on viewers' favorite stocks.

  • The "Big Bank Theory" Of Picking Stocks Thursday, 12 Feb 2009 | 1:33 PM ET

    CNBC's "Power Lunch" team asked some of the best and the brightest from America's big financial firms to list the most promising stocks. Strategists from Citigroup, Goldman Sachs, Cowen & Co. and Deutsche Bank offered CNBC their stock picks.

  • A Tale Of Two Industries Tuesday, 13 Jan 2009 | 12:25 PM ET
    Jamie Dimon

    During his lunchtime keynote speech here at the JPMorgan Healthcare Conference JPM Chairman and CEO Jamie Dimon was asked to give his worst-case scenario for the economy. He said that'd be a 1982-type recession lasting about two years and with unemployment "North of 10 percent." Dimon said it would be "Irrational to not be prepared for that."

  • '09 Sector To Watch: Biotech Monday, 5 Jan 2009 | 6:06 PM ET

    Will M&A activity boost biotech stocks in 2009?

  • Vertex's $75,000 Question Friday, 19 Dec 2008 | 3:14 PM ET

    Drug pricing pressure under a Democratic administration be darned. $75,000. That's not a salary figure. That's the price one biotech analyst says Vertex Pharmaceuticals and its partner Johnson & Johnson might be able to charge--possibly even more--for their Hepatitis C drug.

  • Mad Mail: Throw Merck Out With Schering? Wednesday, 3 Sep 2008 | 6:36 PM ET

    Plus, Cramer make the call on IBM, CSX, Celgene and more.

  • Putting Cramer in Context Friday, 15 Aug 2008 | 7:18 PM ET

    This is how you balance Mad Money stock picks with your own portfolio.

  • Speculating on Alexion Pharma Thursday, 14 Aug 2008 | 11:44 PM ET

    This biotech sells its treatment to a niche clientele for big money.

  • Worst House, Best Neighborhood Wednesday, 13 Aug 2008 | 11:09 PM ET

    Vertex Pharma is lagging its peers. But biotech is so good right now, it might not matter.